Uracil

Uracil

SCHEMBL4652740

CC(=O)O.CC(=O)O.O=c1cc[nH]c(=O)[nH]1

nearest known ligand 0.74

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Uracil. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CRBN Q96SW2 2/20 0.74
▸ MMP2 P08253 2/20 0.46
▸ TP53 P04637 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ CYP1A2 P05177 1/20 0.33
▸ PDE3B Q13370 1/20 0.33
▸ PDE3A Q14432 1/20 0.33
▸ TYMP P19971 1/20 0.32
▸ GSK3B P49841 1/20 0.32
▸ BACE1 P56817 1/20 0.32
▸ NOTUM Q6P988 1/20 0.32
▸ NAPRT Q6XQN6 1/20 0.32
▸ CA1 P00915 1/20 0.32
▸ GAA P10253 1/20 0.31
▸ ATAD2 Q6PL18 1/20 0.31
▸ MMP1 P03956 1/20 0.31
▸ MMP9 P14780 1/20 0.31
▸ MMP12 P39900 1/20 0.31
▸ FFAR3 O14843 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Uracil SCHEMBL479740 1.00 CRBN (0.74) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL2895220 0.98 CRBN (0.71) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL9429688 0.89 CRBN (0.77) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL25208560 0.88 CRBN (0.63) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL2895224 0.88 CRBN (0.68) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL11607890 0.86 — —
Uracil SCHEMBL8235 0.86 — —
Uracil SCHEMBL3798527 0.86 CRBN (1.00) CRBNMMP2TP53ALDH1A1LMNA
Uracil SCHEMBL5089507 0.86 — —
Uracil SCHEMBL21385227 0.84 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 304 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240204183-A1 HIGH-NICKEL POSITIVE ELECTRODE MATERIAL AND PREPARATION METHOD THEREFOR, AND LITHIUM ION BATTERY BTR NANO TECH CO., LTD. (CN) 2024-06-20 — — US claimed
EP-4280304-A1 NICKEL-RICH POSITIVE ELECTRODE MATERIAL, PREPARATION METHOD THEREFOR, AND LITHIUM ION BATTERY BTR NANO TECH CO., LTD. (CN) 2023-11-22 — — EP claimed
WO-2023103700-A1 NICKEL-RICH POSITIVE ELECTRODE MATERIAL, PREPARATION METHOD THEREFOR, AND LITHIUM ION BATTERY 深圳市贝特瑞纳米科技有限公司 2023-06-15 — — WO claimed
CN-116247195-A High-nickel positive electrode material, preparation method thereof and lithium ion battery 深圳市贝特瑞纳米科技有限公司 2023-06-09 — — CN claimed
JP-2265191-A — — None — — JP disclosed
US-12620589-B2 Method for producing positive electrode active material for lithium secondary battery and method for producing positive electrode for lithium secondary battery SUMITOMO METAL MINING CO., LTD. (JP) 2026-05-05 — — US disclosed
US-20260066280-A1 LITHIUM METAL COMPOSITE OXIDE POWDER, POSITIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERIES, POSITIVE ELECTRODE, AND LITHIUM SECONDARY BATTERY SUMITOMO METAL MINING CO (JP) 2026-03-05 — — US disclosed
US-20260062313-A1 NICKEL-CONTAINING HYDROXIDE, CATHODE ACTIVE MATERIAL WITH NICKEL-CONTAINING HYDROXIDE AS PRECURSOR, AND METHOD FOR PRODUCING NICKEL-CONTAINING HYDROXIDE TANAKA CHEMICAL CORPORATION (JP) 2026-03-05 — — US disclosed
US-20260062314-A1 METAL COMPOSITE COMPOUND AND CATHODE ACTIVE MATERIAL WITH METAL COMPOSITE COMPOUND AS PRECURSOR TANAKA CHEMICAL CORPORATION (JP) 2026-03-05 — — US disclosed
EP-4700864-A1 LITHIUM METAL COMPOSITE OXIDE POWDER, POSITIVE ELECTRODE ACTIVE MATERIAL FOR SOLID SECONDARY BATTERY, POSITIVE ELECTRODE FOR SOLID SECONDARY BATTERY, AND SOLID SECONDARY BATTERY Sumitomo Chemical Company, Limited (JP) 2026-02-25 — — EP disclosed
US-20260045495-A1 CATHODE MATERIAL, CATHODE SLURRY AND LITHIUM ION BATTERY BTR NANO TECH CO., LTD. (CN) 2026-02-12 — — US disclosed
EP-4675707-A1 POSITIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERY, POSITIVE ELECTRODE FOR LITHIUM SECONDARY BATTERY, AND LITHIUM SECONDARY BATTERY Sumitomo Chemical Company, Limited (JP) 2026-01-07 — — EP disclosed
US-20060115776-A1 Photothermographic material FUJI PHOTO FILM CO., LTD. 2006-06-01 — — US disclosed
US-20060057511-A1 Photothermographic material FUJI PHOTO FILM CO., LTD. 2006-03-16 — — US disclosed
US-20060057512-A1 Photothermographic material FUJI PHOTO FILM CO., LTD. 2006-03-16 — — US disclosed
EP-1635216-A1 Photothermographic material FUJI PHOTO FILM CO., LTD. (JP) 2006-03-15 — — EP disclosed
EP-1582919-A1 Silver halide photosensitive material and photothermographic material Fuji Photo Film Co. Ltd. (JP) 2005-10-05 — — EP disclosed
US-20050214700-A1 Silver halide photosensitive material and photothermographic material FUJI PHOTO FILM CO., LTD. 2005-09-29 — — US disclosed
US-20050208438-A1 Photothermographic material and image forming method FUJIFILM CORPORATION (JP) 2005-09-22 — — US disclosed
JP-H02265191-A ELECTRIC WAVE ABSORBER MURATA MFG CO LTD 1990-10-29 — — JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260062314-A1 METAL COMPOSITE COMPOUND AND CATHODE ACTIVE MATERIAL WITH METAL COMPOSITE COMPOUND AS PRECURSOR CACNA2D4, CACNA2D2, CACNA2D1 CRBN 3888/4885MMP2 2196/4885TP53 2891/4885
US-12620589-B2 Method for producing positive electrode active material for lithium secondary battery and method for producing positive electrode for lithium secondary battery CACNA2D2, CACNA2D1, CACNA2D4 CRBN 2476/4885MMP2 950/4885TP53 2517/4885
US-20260066280-A1 LITHIUM METAL COMPOSITE OXIDE POWDER, POSITIVE ELECTRODE ACTIVE MATERIAL FOR LITHIUM SECONDARY BATTERIES, POSITIVE ELECTRODE, AND LITHIUM SECONDARY BATTERY MLX, CACNA2D1, CACNA2D3 CRBN 2634/4885MMP2 1973/4885TP53 1699/4885
US-20260062313-A1 NICKEL-CONTAINING HYDROXIDE, CATHODE ACTIVE MATERIAL WITH NICKEL-CONTAINING HYDROXIDE AS PRECURSOR, AND METHOD FOR PRODUCING NICKEL-CONTAINING HYDROXIDE CACNA2D4, NNT, CACNA2D1 CRBN 4742/4885MMP2 1105/4885TP53 1423/4885
US-20260045495-A1 CATHODE MATERIAL, CATHODE SLURRY AND LITHIUM ION BATTERY SCO2, LBR, SOD1 CRBN 1317/4885MMP2 3469/4885TP53 3085/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback